See the Full Respiratory Picture
Continuously measure lung sounds, including cough and wheeze, from anywhere with the RESP® Biosensor
As Featured In
Quantify Cough and Lung Sounds
Stethoscope auscultation is key in identifying abnormal sounds to diagnose and monitor respiratory diseases, yet it has been limited to in-person, episodic visits. The RESP® Biosensor is the first FDA-cleared device to provide a continuous, passive measurement of patients’ lung sounds from hospital to home.
For Health Systems
Enhance surveillance and management of patients with chronic respiratory diseases
For Clinical Trials
Strengthen insight into treatment response alongside patient-reported outcomes
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Wearable biosensor passively and continuously collects lung sounds and physiological data
RESP® Cloud
Captured data are securely and wirelessly transferred to HIPAA-compliant cloud for overread
Patient Reports
Client receives detailed patient reports
1M+
Lung Sounds Captured
30M+
Breaths Captured
4
35
2
1
The Award-Winning Digital Health Technology for Lung Health
Privacy & Security
Designed for Daily Life
Low-burden, discreet design aids patient comfort while accurately collecting data in the real world.
Global Experience
Used in patients and subjects in four continents and 35 languages.
Beyond Cough
Extended capabilities beyond cough frequency include intensity, bouts, lung sounds and vitals* for a fuller understanding of patient health.
Clinically Validated Accuracy
*Measurement not FDA-cleared
FAQ
Frequently Asked Questions and Technical Specifications
News & Resources
Strados Labs to Present Developments in Cough Monitoring at ATS 2025
Strados Labs looks forward to participating in the American Thoracic Society (ATS) 2025 International Conference from May 16–21 in San Francisco, CA. Please join us as we present sessions highlighting the importance of cough in respiratory diseases, along...
Webinar Replay: From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments
Dr. Peter Cho's section focused on cough in ILDs (on behalf of Strados Labs) from 28:52 - 39:40. Interstitial lung disease (ILD) represents a diverse group of disorders characterized by infiltration of lung parenchyma with extracellular matrix, leading to progressive...
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring
The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system. Philadelphia, PA, March 20, 2025 – Strados Labs, a medical technology company, is announcing the launch of a new grant initiative developed to accelerate...
Let's Talk
Speak to one of our respiratory experts to learn more